Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.bcp.2013.12.024
10.1016/j.bcp.2013.12.024 · External reference
10.1111/cts.12491
10.1111/cts.12491 · External reference
Precision medicine - the golden gate for detection, treatment and prevention of Alzheimer's disease.
2016 · External reference
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
10.1186/s13195-021-00951-z · 2022 · External reference
10.1038/s43587-021-00138-z
10.1038/s43587-021-00138-z · External reference
10.1002/med.21709
10.1002/med.21709 · External reference
Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.
10.1016/j.ejmech.2018.10.020 · 2019 · External reference
10.1016/j.fct.2020.111767
10.1016/j.fct.2020.111767 · External reference
Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
10.1038/s41467-021-21330-0 · 2021 · External reference
10.1016/j.celrep.2022.111717
10.1016/j.celrep.2022.111717 · External reference
10.1093/bib/bbv048
10.1093/bib/bbv048 · External reference
10.1007/bf00308809
10.1007/bf00308809 · External reference
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
10.1212/01.wnl.0000152982.47274.9e · 2005 · External reference
10.1016/j.neubiorev.2021.07.007
10.1016/j.neubiorev.2021.07.007 · External reference
AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
10.1186/s13195-020-00760-w · 2021 · External reference
A genome-wide positioning systems network algorithm for in silico drug repurposing.
10.1038/s41467-019-10744-6 · 2019 · External reference
10.1038/s41586-019-1195-2
10.1038/s41586-019-1195-2 · External reference
10.1038/s41593-019-0539-4
10.1038/s41593-019-0539-4 · External reference
admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties.
2019 · External reference
10.1016/j.bbrc.2017.06.108
10.1016/j.bbrc.2017.06.108 · External reference
10.1016/s0736-5748(00)00010-1
10.1016/s0736-5748(00)00010-1 · External reference
10.1016/j.celrep.2013.12.005
10.1016/j.celrep.2013.12.005 · External reference
Sunitinib, a clinically used anticancer drug, is a potent AChE inhibitor and attenuates cognitive impairments in mice
10.1021/acschemneuro.5b00329 · 2016 · External reference
Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models
10.1016/j.neuroscience.2015.07.070 · 2015 · External reference
10.1080/07853890510037347
10.1080/07853890510037347 · External reference
10.1097/jgp.0b013e3181ab8c3f
10.1097/jgp.0b013e3181ab8c3f · External reference
Polymorphisms in the cholinergic receptors muscarinic and genes and Alzheimer's disease
2018 · External reference
10.1371/journal.pone.0021660
10.1371/journal.pone.0021660 · External reference
10.1038/s41423-019-0294-1
10.1038/s41423-019-0294-1 · External reference
10.1177/0271678x19873658
10.1177/0271678x19873658 · External reference
GABAB receptor-mediated PI3K/Akt signaling pathway alleviates oxidative stress and neuronal cell injury in a rat model of Alzheimer's disease
10.3233/jad-191032 · 2020 · External reference
10.1111/jnc.14345
10.1111/jnc.14345 · External reference
Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk
10.1371/journal.pone.0229541 · 2020 · External reference
Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice
10.1371/journal.pone.0171515 · 2017 · External reference
Nilvadipine prevents cognitive decline of patients with mild cognitive impairment
10.1002/gps.1851 · 2007 · External reference
The association between the usage of non-steroidal anti-inflammatory drugs and cognitive status: analysis of longitudinal and cross-sectional studies from the global alzheimer's association interactive network and transcriptomic data
10.3390/brainsci10120961 · 2020 · External reference
Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial
10.1016/j.biopsych.2013.08.010 · 2014 · External reference
Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects
10.1007/s11011-018-0374-4 · 2019 · External reference
10.1126/science.aaf1204
10.1126/science.aaf1204 · External reference
10.1038/s41586-019-1506-7
10.1038/s41586-019-1506-7 · External reference
10.1016/j.brainres.2005.04.014
10.1016/j.brainres.2005.04.014 · External reference
Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice
10.1016/j.brainres.2017.09.019 · 2017 · External reference
Dexibuprofen (S(+)-isomer ibuprofen) reduces microglial activation and impairments of spatial working memory induced by chronic lipopolysaccharide infusion
10.1016/j.pbb.2008.01.016 · 2008 · External reference
New insights in drug development for Alzheimer's disease based on microglia function
10.1016/j.biopha.2021.111703 · 2021 · External reference
Carvedilol promotes retinal ganglion cell survival following optic nerve injury via ASK1-p38 MAPK pathway
10.2174/1871527318666191002095456 · 2019 · External reference
Neuroprotective effects of FK-506, L-carnitine and azathioprine on spinal cord ischemia-reperfusion injury
10.1016/s1010-7940(03)00582-7 · 2004 · External reference
10.3390/cells9102286
10.3390/cells9102286 · External reference
Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model
10.1016/j.pbb.2019.172828 · 2020 · External reference
Panaxadiol inhibits synaptic dysfunction in Alzheimer's disease and targets the Fyn protein in APP/PS1 mice and APP-SH-SY5Y cells
10.1016/j.lfs.2019.02.012 · 2019 · External reference
FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells
10.1007/s00210-013-0918-4 · 2014 · External reference
10.1089/ars.2021.0177
10.1089/ars.2021.0177 · External reference
Inhibition of Rac1 in ventral hippocampal excitatory neurons improves social recognition memory and synaptic plasticity
10.3389/fnagi.2022.914491 · 2022 · External reference
10.1007/s12035-021-02471-1
10.1007/s12035-021-02471-1 · External reference
10.1373/jalm.2018.027623
10.1373/jalm.2018.027623 · External reference
Apoptosis and Alzheimer's disease
10.1007/s007020070021 · 2000 · External reference
Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss
10.1016/j.phymed.2021.153662 · 2021 · External reference
Drug repurposing for Alzheimer's disease based on transcriptional profiling of human iPSC-derived cortical neurons
10.1038/s41398-019-0555-x · 2019 · External reference
